Bekaii-Saab T - Search Results

1

Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial.

Jatoi A, Ou FS, Ahn DH, Zemla TJ, Le-Rademacher JG, Boland P, Ciombor KK, Jacobs NL, Pasche B, Cleary JM, McCune JS, Pedersen KS, Barzi A, Chiorean EG, Heying EN, Lenz HJ, Sloan JA, Grothey A, Lacouture ME, Bekaii-Saab T. Jatoi A, et al. Oncologist. 2021 Jul;26(7):610-618. doi: 10.1002/onco.13730. Epub 2021 Mar 6. Oncologist. 2021. PMID: 33604969 Free PMC article. Clinical Trial.

2

Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.

Bendell JC, Bekaii-Saab TS, Cohn AL, Hurwitz HI, Kozloff M, Tezcan H, Roach N, Mun Y, Fish S, Flick ED, Dalal D, Grothey A. Bendell JC, et al. Oncologist. 2012;17(12):1486-95. doi: 10.1634/theoncologist.2012-0190. Epub 2012 Sep 26. Oncologist. 2012. PMID: 23015662 Free PMC article.

3

Emerging treatments in recurrent and metastatic colorectal cancer.

Ciombor KK, Bekaii-Saab T. Ciombor KK, et al. J Natl Compr Canc Netw. 2013 Sep;11 Suppl 4(Suppl 4):S18-27. doi: 10.6004/jnccn.2013.0217. J Natl Compr Canc Netw. 2013. PMID: 24158967 Free PMC article. Review.

4

Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.

Grothey A, Flick ED, Cohn AL, Bekaii-Saab TS, Bendell JC, Kozloff M, Roach N, Mun Y, Fish S, Hurwitz HI. Grothey A, et al. Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):726-34. doi: 10.1002/pds.3633. Epub 2014 May 16. Pharmacoepidemiol Drug Saf. 2014. PMID: 24830357

5

Ampullary cancer: an overview.

Ahn DH, Bekaii-Saab T. Ahn DH, et al. Am Soc Clin Oncol Educ Book. 2014:112-5. doi: 10.14694/EdBook_AM.2014.34.112. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857067 Free PMC article. Review.

6

Selumetinib for the treatment of cancer.

Ciombor KK, Bekaii-Saab T. Ciombor KK, et al. Expert Opin Investig Drugs. 2015 Jan;24(1):111-123. doi: 10.1517/13543784.2015.982275. Epub 2014 Nov 11. Expert Opin Investig Drugs. 2015. PMID: 25385055

7

Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value.

Ahn DH, Ko AH, Meropol NJ, Bekaii-Saab TS. Ahn DH, et al. Am Soc Clin Oncol Educ Book. 2015:e222-7. doi: 10.14694/EdBook_AM.2015.35.e222. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993177 Free PMC article. Review.

8

Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer.

Ahn DH, Li J, Wei L, Doyle A, Marshall JL, Schaaf LJ, Phelps MA, Villalona-Calero MA, Bekaii-Saab T. Ahn DH, et al. Sci Rep. 2015 Jul 10;5:12122. doi: 10.1038/srep12122. Sci Rep. 2015. PMID: 26161813 Free PMC article. Clinical Trial.

9

Adjuvant therapy for pancreas cancer in an era of value based cancer care.

Ahn DH, Williams TM, Goldstein DA, El-Rayes B, Bekaii-Saab T. Ahn DH, et al. Cancer Treat Rev. 2016 Jan;42:10-7. doi: 10.1016/j.ctrv.2015.11.004. Epub 2015 Nov 24. Cancer Treat Rev. 2016. PMID: 26620819 Free PMC article. Review.

10

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.

Ahn DH, Ozer HG, Hancioglu B, Lesinski GB, Timmers C, Bekaii-Saab T. Ahn DH, et al. Oncotarget. 2016 Feb 2;7(5):5306-12. doi: 10.18632/oncotarget.6632. Oncotarget. 2016. PMID: 26683364 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters